.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
UBS
McKesson
Johnson and Johnson
Accenture
AstraZeneca
Baxter
Cantor Fitzgerald
Federal Trade Commission
Novartis

Generated: December 17, 2017

DrugPatentWatch Database Preview

PRIMSOL Drug Profile

« Back to Dashboard

Which patents cover Primsol, and when can generic versions of Primsol launch?

Primsol is a drug marketed by Allegis and Aytu Pharms and is included in two NDAs. There are two patents protecting this drug.

This drug has thirteen patent family members in eleven countries.

The generic ingredient in PRIMSOL is trimethoprim hydrochloride. There are thirty-three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the trimethoprim hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
AllegisPRIMSOLtrimethoprim hydrochlorideSOLUTION;ORAL074973-001Jan 24, 2000RXYesYes► Subscribe► Subscribe► Subscribe
AllegisPRIMSOLtrimethoprim hydrochlorideSOLUTION;ORAL074973-001Jan 24, 2000RXYesYes► Subscribe► Subscribe► Subscribe
Aytu PharmsPRIMSOLtrimethoprim hydrochlorideSOLUTION;ORAL074374-001Jun 23, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Premature patent expiration for: PRIMSOL

Expiration due to failure to pay maintenance fee

Patent Number Tradename Expiration Date
► Subscribe PRIMSOL ► Subscribe

International Patent Family for Tradename: PRIMSOL

Country Document Number Estimated Expiration
European Patent Office0938302► Subscribe
Germany69720759► Subscribe
Slovenia938302► Subscribe
Australia3913297► Subscribe
Canada2260852► Subscribe
Spain2196355► Subscribe
Japan3778518► Subscribe
Austria236624► Subscribe
Australia727175► Subscribe
Denmark0938302► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Accenture
Argus Health
Colorcon
Covington
Harvard Business School
Cerilliant
Julphar
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot